Dexmedetomidine Injection, Solution, Concentrate
Product Images NDC 83634-600

2 FDA label images from Avenacy Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dexmedetomidine (NDC 83634-600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avenacy Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Dex1v 0001 01)

Structural Formula (Dex1v 0001 01)
Chemical structure of dexmedetomidine hydrochloride, showing the molecular arrangement of the active ingredient dexmedetomidine with a hydrochloride component indicated.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Dex1v 0001 02)

Package Label – Principal Display Panel – Vial Label (Dex1v 0001 02)
Dexmedetomidine Injection USP label, containing 200 mcg (base) per 2 mL (100 mcg base per mL) concentrate for intravenous use. It is a 2 mL single-dose vial, with instructions that the solution must be diluted and unused portions discarded. Manufactured for Avenacy Inc., Schaumburg, IL, made in China, with lot and expiration date fields blanked out. The label includes an NDC number 83634-600-41 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.